Dr Armin Schwarzbach’s Presentation on Modern tests  2018

Dr Schwarzbach discusses why these tests are insufficient to detect chronic lyme disease.  He then discusses new methods of testing and talks about the immune system. He mentions Low Dose Naltrexone (LDN) as an adjuvant therapy in helping quelle the subsequent inflammation related to the infections. 

Low Dose Naltrexone (LDN), seems to work very well as another tool for treating Lyme Disease.

Thank you for listening to this presentation. All past conference presentations can be found on our website, www.ldnresearchtrust.org/ldn-conferences